Author:
Belén Jiménez Muñoz Ana,Muiño Miguez Antonio,Paz Rodriguez Pérez María,Dolores Vigil Escribano María,Esther Durán Garcia María,Sanjurjo Saez María
Abstract
PurposeHealthcare risk epidemiology identifies medication error as the commonest cause of adverse effects on patients. Medication error can occur at any phase of the complex medication process so prevalence rates need to be estimated at each drug treatment phase: prescription, transcription and administration along with their clinical repercussions. This paper aims to investigate this issue.Design/methodology/approachMedication errors were recorded on an ad hoc sheet and staff were observed handling medications. Recorded errors were later classified and their clinical repercussions determined by experts.FindingsIn total 757 inpatients and 5,466 drug prescriptions were studied. The prescription error rate was 4.79 percent (95 percent CI 4.21‐5.36). The most frequent error in this phase was failing to observe international prescribing standards. The highest error rate was found in transcription (14.61 percent, 95 percent CI 13.67‐15.54). Almost 1,900 dose administrations were observed. There was a 9.32 percent error rate (95 percent CI 7.98‐10.67). The commonest error in this phase was omission. Most were transcription errors, which were detected before harm was done.Research limitations/implicationsThe dispensation phase is absent.Practical implicationsErrors can be reduced if they are understood. Education and training based on the study's findings can reduce medication errors.Originality/valueThe paper highlights ways to reduce errors in the medication process.
Subject
Health Policy,General Business, Management and Accounting
Reference34 articles.
1. American Society of Hospital Pharmacists (1993), “ASHP guidelines on preventing medical errors in hospitals”, American Journal of Hospital Pharmacy, Vol. 50 No. 2, pp. 305‐14.
2. Aranaz, J.M. and Vitaller Burillo, J. (2004), De las complicaciones y efectos adversos a la gestión de los riesgos de la asistencia sanitaria, 1st ed., Escuela Valenciana de estudios en salud, Industrias graficas ECIR SA, Valencia.
3. Baker, G.R. et al., (2004), “The Canadian Adverse Events study: the incidence of adverse events among hospital patients in Canada”, Canadian Medical Association Journal, Vol. 170 No. 11, pp. 1678‐86.
4. Bates, D.W. et al., (1995), “Incidence of adverse drug events and potential drug events. Implications for prevention”, The Journal of American Association, Vol. 274 No. 1, pp. 29‐34.
5. Bobb, A., Gleason, K., Hursch, M., Feinglass, J., Yarnold, P.R. and Noskin, G.A. (2004), “The epidemiology of prescribing errors: the potential impact of computerized prescriber order entry”, Archives of Internal Medicine, Vol. 164 No. 7, pp. 785‐92.
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献